Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $4.03 billion as of June 13, 2025. Its market cap has decreased by -20.51% in one year.

Market Cap

4.03B

Enterprise Value

3.99B

1-Year Change

-20.51%

Ranking

#1452

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $4.03B, an increase of 860.15%. That is a compound annual growth rate of 11.30%.

Market Cap History

Date	Market Cap	% Change
Jun 11, 2025	3.95B	-28.77%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	732.84B
Johnson & Johnson	374.96B
Novo Nordisk	353.21B
AbbVie	337.65B
UnitedHealth Group	287.39B
Abbott Laboratories	236.01B
Novartis AG	231.84B
AstraZeneca	229.07B

Market Cap Rankings